Neurological update: MOG antibody disease

Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. Although no age group is exempt, median age of onset is within the fourth decade of life, with optic neuritis being t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2019-05, Vol.266 (5), p.1280-1286
Hauptverfasser:	Wynford-Thomas, Ray, Jacob, Anu, Tomassini, Valentina
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies - blood Aquaporin 4 - metabolism Cerebrospinal fluid Clinical trials Humans Immunosuppressive agents Inflammation Inflammatory diseases Magnetic resonance imaging Medicine Medicine & Public Health Monoclonal antibodies Multiple sclerosis Myelin Myelin-Oligodendrocyte Glycoprotein - immunology Myelitis Neuritis Neurological Update Neurology Neuromyelitis Neuromyelitis Optica - blood Neuromyelitis Optica - complications Neuromyelitis Optica - therapy Neuroradiology Neurosciences Oligodendrocyte-myelin glycoprotein Optic nerve Optic neuritis Optic Neuritis - blood Optic Neuritis - complications Optic Neuritis - therapy Phenotypes Plasma Exchange - methods Rituximab Steroid hormones Steroids - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!